Renee Leck | Director, Investor Relations |
Mark Rothera | President, Chief Executive Officer |
Bobby Gaspar | Co-Founder and Chief Scientific Officer |
Andrea Spezzi | Co-Founder and Chief Medical Officer |
Frank Thomas | Chief Financial Officer |
Anupam Rama | JPMorgan |
Graig Suvannavejh | Goldman Sachs |
David Nierengarten | Wedbush Securities |
Good day, ladies and gentlemen, and welcome to the Orchard Therapeutics Fourth Quarter 2018 Earnings Conference Call. At this time all participants are in a listen-only mode. And later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] I would now like to hand the call over to Ms. Renee Leck, Director of Investor Relations.